HHS Secretary Alex Azar said the department is looking to change Medicaid's drug-rebate guidelines to prevent drugmakers from gaming the program, and it will start by blocking pharmaceutical firms from using line extensions to reduce the rebates they have to pay to states. Speaking at an event of the American Legislative Exchange Council, Azar said he also plans to address certificate-of-need rules, which serve as a "significant barrier to new competition and lower-cost market disruptors."
Azar looks to overhaul Medicaid drug-rebate guidelines
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.